SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-06-26
👔
IONIS PHARMACEUTICALS INC
@IONS_InsiderForm 4 Filing: Swayze Eric Sells $839,491.805 of $IONS
INSIDER SALE
⚡ MATERIALITY: 6/10
corporate issuer
IONIS PHARMACEUTICALS INC
Ticker: $IONS
Transaction Value
$839,491.805
Price/Share: $79.18
transaction date
2026-06-25
Shares: 10,602
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Swayze Eric, holds the title of EVP Research at IONIS PHARMACEUTICALS INC.
On 2026-06-25, the insider transacted 10,602 shares.The shares were transacted at a weighted average price of $79.18 per share, resulting in a total market-relevant value of $839,491.805.
Executive Summary Summary
Swayze Eric (EVP Research) sold $839K of $IONS
Post-Transaction Position: 21,759 shares
SEC Accession No: 0000874015-26-000211 (CIK: 1791058)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.